TG Therapeutics, Inc. (TGTX): Price and Financial Metrics
TGTX Price/Volume Stats
Current price | $36.72 | 52-week high | $46.48 |
Prev. close | $36.29 | 52-week low | $16.65 |
Day low | $36.07 | Volume | 681,300 |
Day high | $36.96 | Avg. volume | 2,537,605 |
50-day MA | $37.04 | Dividend yield | N/A |
200-day MA | $32.69 | Market Cap | 5.83B |
TGTX Stock Price Chart Interactive Chart >
TG Therapeutics, Inc. (TGTX) Company Bio
TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The company was founded in 1993 and is based in New York, New York.
TGTX Price Returns
1-mo | -0.85% |
3-mo | -1.69% |
6-mo | 22.20% |
1-year | N/A |
3-year | 599.43% |
5-year | N/A |
YTD | 21.99% |
2024 | 76.23% |
2023 | 44.38% |
2022 | -37.74% |
2021 | -63.48% |
2020 | 368.65% |
Continue Researching TGTX
Want to see what other sources are saying about Tg Therapeutics Inc's financials and stock price? Try the links below:Tg Therapeutics Inc (TGTX) Stock Price | Nasdaq
Tg Therapeutics Inc (TGTX) Stock Quote, History and News - Yahoo Finance
Tg Therapeutics Inc (TGTX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...